Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

HealthRX vs LeanDose

HealthRX
Site position #36

Higher grade

vs+10.4
LeanDose
Site position #189

Lower grade

The verdict

HealthRX takes it — 77.5/100 to 67.1/100.

HealthRX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. HealthRX’s current injection plans disclose the first charge and renewal separately. The lowest monthly equivalents require a prepaid year; a monthly subscription offers a smaller initial commitment.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHealthRX +19
85
66
Dose & formulationEven
64
64
Clinical oversightHealthRX +8
87
79
Labs & monitoringHealthRX +28
82
54
FulfillmentHealthRX +7
86
79
Contract termsLeanDose +12
43
55
HealthRX · left barLeanDose · right bar

The numbers

MetricHealthRXLeanDose
WeighScore77.5/10067.1/100
GradeC+C
Site position#36#189
Semaglutide$149 first month, then $165/month; $1,163 per 12-month subscription$159/mo (first-month rate, compounded)
Tirzepatide$193 first month, then $214/month; $2,123 per 12-month subscription$279/mo (first-month rate, compounded)
CoverageNot publicly listedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
HealthRX

Site position #36 · C+

Strengths

  • Product pages publish due-today and next-charge tables
  • Medication if approved, provider review and overnight shipping are included
  • Longer plans offer a one-time purchase option without automatic renewal

Where it loses points

  • Annual headline rates require payment for 12 months upfront
  • Monthly subscription prices rise after the first payment
  • Product navigation still shows older starting prices
  • Injection supplies are not confirmed as standard inclusions
LeanDose

Site position #189 · C

Strengths

  • Transparent all-inclusive first-month pricing (compounded semaglutide from $159, tirzepatide from $279)
  • FDA-registered compounding pharmacy
  • Doctor-prescribed and supervised, with personalized care plans and multi-state clinical support
  • Convenient at-home delivery; compounded semaglutide and tirzepatide options
  • Honest, modest social proof — 119 five-star patient reviews

Where it loses points

  • Compounded medications are not FDA-approved — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • Headline rates are first-month pricing; your ongoing monthly cost may be higher
  • Available in multiple states but the full list is not published on the homepage
  • The compounding pharmacy is FDA-registered but not named

Featured provider

HealthRX

HealthRX scores 77.5/100 (C+). HealthRX’s current injection plans disclose the first charge and renewal separately. The lowest monthly equivalents require a prepaid year; a monthly subscription offers a smaller initial commitment.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard